The episode begins with host Kevin Gettings introducing Dr. Michael Koren, who recently returned from a major cardiovascular health conference in New Orleans. Dr. Koren identifies two primary areas of innovation: AI's impact on healthcare and gene editing based on human genetics. He explains that medicine has historically focused on managing diseases rather than curing them, but gene editing studies for cholesterol aim to cure the underlying genetic basis. Dr. Koren notes that Northeast Florida is leading the country in these gene editing initiatives. The discussion shifts to American ingenuity, referencing Benjamin Franklin's philosophy that values capability over lineage, which Dr. Koren links to U.S. leadership in medical innovation. Kevin Gettings then asks about clinical trial participation, and Dr. Koren describes ongoing trials for conditions like weight loss, blood clots, atrial fibrillation, and orthopedic surgery. He emphasizes that participants receive personalized assessments and cutting-edge care, sharing that he is currently in a trial and recommends the experience. The episode ends with a closing thought supporting ingenuity and innovation, directing listeners to MedEvidence.com for more information.
